Biohaven Pharmaceutical Holding Company Ltd. Stock

$20.55

13.22% yesterday

NYSE, Apr 03, 10:00 pm CET

ISIN

VGG111961055

Symbol

BHVN

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Biohaven Pharmaceutical Holding Company Ltd. Stock price

$20.55

-8.46 29.16% 5Y

NYSE, Closing price Thu, Apr 03 2025

-3.13 13.22%

ISIN

VGG111961055

Symbol

BHVN

Reports

Quarter | Annual

Index

NYSE Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Market capitalization	$2.10b
Enterprise Value	$1.65b
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	negative
P/B ratio (TTM) P/B ratio	4.91
Revenue (TTM) Revenue	$0.00
EBIT (operating result TTM) EBIT	$-885.11m
Free Cash Flow (TTM) Free Cash Flow	$-586.50m
Cash position	$486.27m
EPS (TTM) EPS	$-9.39
P/E forward	negative
P/S forward	102.83
EV/Sales forward	80.78
Short interest	8.11%

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Get Started for Free Today

Biohaven Pharmaceutical Holding Company Ltd. Stock Analysis

Unlock Scores for Free

??

16 Analysts have issued a Biohaven Pharmaceutical Holding Company Ltd. forecast:

16x Buy

100%

More details on Analyst Estimates Including Price Targets

16 Analysts have issued a Biohaven Pharmaceutical Holding Company Ltd. forecast:

Buy

100%

Analyst Estimates with Stock Price Targets

Financial data from Biohaven Pharmaceutical Holding Company Ltd.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	- -	- 100%
- Direct Costs	3.92 3.92	16% 16% -
Gross Profit	-3.92 -3.92	16% 16% -
- Selling and Administrative Expenses	81 81	45% 45% -
- Research and Development Expense	796 796	113% 113% -
EBITDA	-881 -881	104% 104% -
- Depreciation and Amortization	3.92 3.92	16% 16% -
EBIT (Operating Income) EBIT	-885 -885	103% 103% -
Net Profit	-846 -846	107% 107% -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Biohaven Pharmaceutical Holding Company Ltd. Stock News

Negative

The Motley Fool

●

about 20 hours ago

Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March

Shares of early-stage biotech stocks, including Biohaven (BHVN -6.50%), Recursion Pharmaceuticals (RXRX -4.92%), and CRISPR Therapeutics (CRSP -2.05%), plunged in March, with the stocks down 35.3%, 29.6%, and 22.5%, respectively, according to data from S&P Global Market Intelligence.

Negative

Investors Business Daily

●

about one month ago

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity

Biohaven stock tumbled for the second day running Tuesday after its bipolar mania treatment failed in a three-week study. The post Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity appeared first on Investor's Business Daily.

Neutral

PRNewsWire

●

about one month ago

Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300

Optimized subcutaneous administration of BHV-1300 achieved rapid, deep and sustained lowering of IgG, differentiating Biohaven's new small molecule class of degraders from the monoclonal antibody FcRn-targeting competition. Up to 84% reduction of total IgG was observed with a median reduction of 80% after subcutaneous weekly 1000 mg dosing in the ongoing Phase 1 study.

More Biohaven Pharmaceutical Holding Company Ltd. News

Company Profile

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.

Head office	Virgin Islands, British
CEO	Vladimir Coric
Employees	256
Founded	2022
Website	www.biohaven.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now